Category

Press Releases
By a recent count, researchers have identified more than 100 different cannabinoids in cannabis. Of these, CBD (cannabidiol) and THC (tetrahydrocannabinol) are the best known and most well studied of the cannabinoids. The main cannabinoids are: CBD (Cannabidiol) THC (Δ9–tetrahydrocannabinol) CBN (Cannabinol) CBG (Cannabigerol) CBC (Cannabichromene) CBGV (Cannabigerivarin) THCV (Tetrahydrocannabivarin) CBDV (Cannabidivarin) CBCV (Cannabichromevarin) The […]
Read More
April 2nd, 2018 | Highly Respected Orlando Cancer Doctor to Become Medical Director Diverse Biotech is extremely pleased to announce the execution of a Medical Director Agreement withDr. Sarah Katta of Southwest Cancer Center in Orlando Florida. Since insurance doesn’t cover cannabinoids, oncology patients who are less fortunate and under Southwest Cancer Centers care may […]
Read More
Diverse Biotech to Focus in FDA Clinical trial ORLANDO, FL | June 4th, 2018 Diverse Biotech Inc., is a private biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced it is pursuing preclinical studies of a pipeline compound BRCX014 in adult patients with Glioblastoma. BRCX014 is also […]
Read More
Patents have been filed with the United States Patent and Trademark Office for 14 different areas. An update on this release are forthcoming.
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases

Tag Cloud